Market cap
₹150 Cr
Revenue (TTM)
₹201 Cr
P/E Ratio
22.6
P/B Ratio
1.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 1.00 | 25.28 | 8.22 |
| EBIT | -- | -- | 35.63 | 32.76 | 14.41 |
| Net Profit | -- | -- | 9.57 | 33.00 | 15.43 |
| EPS | -- | -- | 9.57 | 18.10 | 7.49 |
| Book Value | -- | -- | 9.00 | 14.98 | 13.01 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | 5.57 | 5.34 | 4.73 | 6.15 |
| Net Margin
| -- | 3.05 | 2.77 | 3.00 | 3.08 |
| Return on equity
| -- | 10.03 | 7.51 | 10.72 | 10.04 |
| Return on Capital
| -- | 13.11 | 11.35 | 13.56 | 13.33 |
| Return on Assets
| -- | 3.95 | 3.06 | 4.22 | 3.95 |
| Debt to Equity (x)
| -- | -- | 0.52 | 0.44 | 0.64 |
Profitability
ROCE
11.35
Lower than Peers by 0.87
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
11.35
|
13.56
|
13.33
|
--
|
--
|
|
Peer Median
|
12.22
|
21.63
|
27.13
|
26.41
|
--
|
ROE
7.51
Lower than Peers by 1.72
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
7.51
|
10.72
|
10.04
|
--
|
--
|
|
Peer Median
|
9.23
|
18.08
|
23.65
|
21.83
|
--
|
ROA
3.06
Lower than Peers by 2.92
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
3.06
|
4.22
|
3.95
|
--
|
--
|
|
Peer Median
|
5.98
|
9.92
|
11.99
|
10.73
|
--
|
EBIT Margin
5.34
Lower than Peers by 4.33
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
5.34
|
4.73
|
6.15
|
--
|
--
|
|
Peer Median
|
9.68
|
7.64
|
15.61
|
14.45
|
--
|
Net Margin
2.77
Lower than Peers by 2.87
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
2.77
|
3.00
|
3.08
|
--
|
--
|
|
Peer Median
|
5.63
|
8.97
|
12.29
|
11.31
|
--
|
Cash Profit Margin
5.20
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
5.20
|
4.65
|
5.93
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
1.00
Lower than Peers by 6.72
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
1.00
|
51.35
|
--
|
--
|
--
|
|
Peer Median
|
7.71
|
-11.85
|
28.76
|
12.22
|
--
|
EBIT Growth
14.05
Lower than Peers by 17.52
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
14.05
|
16.43
|
--
|
--
|
--
|
|
Peer Median
|
31.57
|
-36.92
|
24.92
|
27.46
|
--
|
Net Profit Growth
-6.90
Lower than Peers by 37.48
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
-6.90
|
47.77
|
--
|
--
|
--
|
|
Peer Median
|
30.59
|
-41.41
|
25.31
|
37.91
|
--
|
EPS Growth
-2.19
Lower than Peers by 33.26
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
-2.19
|
3.58
|
--
|
--
|
--
|
|
Peer Median
|
31.07
|
-42.07
|
26.92
|
38.53
|
--
|
Book Value Growth
7.99
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
7.99
|
76.87
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.52
Higher than Peers by 0.47
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
0.52
|
0.44
|
0.64
|
--
|
--
|
|
Peer Median
|
0.05
|
0.11
|
0.09
|
0.09
|
--
|
Short term debt to equity ratio
0.45
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
0.45
|
0.34
|
0.41
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.52
Lower than Peers by 0.55
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
1.52
|
1.50
|
1.55
|
--
|
--
|
|
Peer Median
|
2.07
|
1.63
|
1.80
|
1.85
|
--
|
Quick Ratio
1.00
Lower than Peers by 0.23
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
1.00
|
1.08
|
1.08
|
--
|
--
|
|
Peer Median
|
1.23
|
1.13
|
0.96
|
1.23
|
--
|
Interest Coverage
2.64
Lower than Peers by 9.58
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
2.64
|
3.39
|
2.71
|
--
|
--
|
|
Peer Median
|
12.22
|
12.03
|
32.38
|
25.98
|
--
|
Operating Efficiency
Debtors to sales
34.54
Higher than Peers by 4.01
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
34.54
|
38.90
|
24.81
|
--
|
--
|
|
Peer Median
|
30.54
|
25.72
|
30.34
|
28.66
|
--
|
Asset Turnover
1.10
Higher than Peers by 0.25
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
1.10
|
1.39
|
1.27
|
--
|
--
|
|
Peer Median
|
0.85
|
0.88
|
1.09
|
1.14
|
--
|
Receivable days
133.34
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
133.34
|
100.91
|
90.55
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
80.71
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
80.71
|
60.65
|
72.84
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
121.49
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
121.49
|
90.76
|
79.13
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
92.56
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
92.56
|
70.80
|
84.26
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
14.84
Lower than Peers by 24.97
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
14.84
|
10.47
|
--
|
--
|
--
|
|
Peer Median
|
39.81
|
50.05
|
19.11
|
27.36
|
--
|
Price / Book Value
1.13
Lower than Peers by 3.47
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
1.13
|
0.88
|
--
|
--
|
--
|
|
Peer Median
|
4.60
|
3.48
|
3.99
|
5.38
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.20
|
0.55
|
0.35
|
0.25
|
--
|
EV/EBITDA
7.31
Lower than Peers by 21.85
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
7.31
|
6.24
|
2.99
|
--
|
--
|
|
Peer Median
|
29.16
|
19.72
|
17.29
|
22.13
|
--
|
Market Cap
87
Lower than Peers by 4,067
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Crop Life Science
|
87
|
63
|
--
|
--
|
--
|
|
Peer Median
|
4,155
|
3,052
|
3,521
|
3,428
|
--
|